Long-acting vs monthly GnRH agonists: A comprehensive review of efficacy, safety, and health-system implications

Hamed Ghiami, Omid Arasteh, Navid Omidkhoda

Open source

DOI
10.1093/ajhp/zxag172
Published
2026-06-08
Container
American Journal of Health-System Pharmacy
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ajhp/zxag172,
  title = {Long-acting vs monthly GnRH agonists: A comprehensive review of efficacy, safety, and health-system implications},
  author = {Hamed Ghiami and Omid Arasteh and Navid Omidkhoda},
  year = {2026},
  journal = {American Journal of Health-System Pharmacy},
  doi = {10.1093/ajhp/zxag172},
  url = {https://doi.org/10.1093/ajhp/zxag172}
}

RIS

TY  - JOUR
TI  - Long-acting vs monthly GnRH agonists: A comprehensive review of efficacy, safety, and health-system implications
AU  - Hamed Ghiami
AU  - Omid Arasteh
AU  - Navid Omidkhoda
PY  - 2026
JO  - American Journal of Health-System Pharmacy
DO  - 10.1093/ajhp/zxag172
UR  - https://doi.org/10.1093/ajhp/zxag172
ER  - 

APA

Ghiami, H., Arasteh, O., & Omidkhoda, N. (2026). Long-acting vs monthly GnRH agonists: A comprehensive review of efficacy, safety, and health-system implications. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxag172

Source records